148 related articles for article (PubMed ID: 25002124)
41. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
42. A cytotoxic monoclonal antibody produced from a human urinary bladder carcinoma cell line (TSGH-8301).
Ma CP; Yeh MY; Yu DS; Jiang SY; Wang CC; Chang SY; Han SH
Proc Natl Sci Counc Repub China B; 1988 Apr; 12(2):101-8. PubMed ID: 3054971
[TBL] [Abstract][Full Text] [Related]
43. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
Mian BM; Dinney CP; Bermejo CE; Sweeney P; Tellez C; Yang XD; Gudas JM; McConkey DJ; Bar-Eli M
Clin Cancer Res; 2003 Aug; 9(8):3167-75. PubMed ID: 12912969
[TBL] [Abstract][Full Text] [Related]
44. Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis.
Martínez-Torrecuadrada JL; Cheung LH; López-Serra P; Barderas R; Cañamero M; Ferreiro S; Rosenblum MG; Casal JI
Mol Cancer Ther; 2008 Apr; 7(4):862-73. PubMed ID: 18413799
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
Chen JF; Yu BX; Yu R; Ma L; Lv XY; Cheng Y; Ma Q
Oncol Rep; 2017 Feb; 37(2):721-728. PubMed ID: 28075465
[TBL] [Abstract][Full Text] [Related]
46. OK-432 Suppresses Proliferation and Metastasis by Tumor Associated Macrophages in Bladder Cancer.
Tian YF; Tang K; Guan W; Yang T; Xu H; Zhuang QY; Ye ZQ
Asian Pac J Cancer Prev; 2015; 16(11):4537-42. PubMed ID: 26107200
[TBL] [Abstract][Full Text] [Related]
47. Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.
Zhao MJ; Song YF; Niu HT; Tian YX; Yang XG; Xie K; Jing YH; Wang DG
Oncotarget; 2016 Feb; 7(8):8956-67. PubMed ID: 26788910
[TBL] [Abstract][Full Text] [Related]
48. Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.
Mitchell K; Svenson KB; Longmate WM; Gkirtzimanaki K; Sadej R; Wang X; Zhao J; Eliopoulos AG; Berditchevski F; Dipersio CM
Cancer Res; 2010 Aug; 70(15):6359-67. PubMed ID: 20631072
[TBL] [Abstract][Full Text] [Related]
49. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
Zhou X; Zhai Y; Liu C; Yang G; Guo J; Li G; Sun C; Qi X; Li X; Guan F
Cell Commun Signal; 2020 Mar; 18(1):44. PubMed ID: 32164705
[TBL] [Abstract][Full Text] [Related]
50. Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
Filipović A; Lombardo Y; Faronato M; Abrahams J; Aboagye E; Nguyen QD; d'Aqua BB; Ridley A; Green A; Rahka E; Ellis I; Recchi C; Przulj N; Sarajlić A; Alattia JR; Fraering P; Deonarain M; Coombes RC
Breast Cancer Res Treat; 2014 Nov; 148(2):455-62. PubMed ID: 25248409
[TBL] [Abstract][Full Text] [Related]
51. Immunotherapy of xenografted human bladder cancer in nude mice using monoclonal antibody.
Yu DS; Yeh MY; Chang SY; Ma CP; Han SH
Eur Urol; 1987; 13(3):198-202. PubMed ID: 3301365
[TBL] [Abstract][Full Text] [Related]
52. Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.
Aggarwal A; Al-Rohil RN; Batra A; Feustel PJ; Jones DM; DiPersio CM
BMC Cancer; 2014 Jun; 14():459. PubMed ID: 24950714
[TBL] [Abstract][Full Text] [Related]
53. A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.
Lee SH; Khwaja Rehman F; Tyler KC; Yu B; Zhang Z; Osuka S; Zerrouqi A; Kaluzova M; Hadjipanayis CG; Cummings RD; Olson JJ; Devi NS; Van Meir EG
Clin Cancer Res; 2020 Jun; 26(11):2711-2724. PubMed ID: 31969339
[TBL] [Abstract][Full Text] [Related]
54. A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor.
Ding S; Nishizawa K; Kobayashi T; Oishi S; Lv J; Fujii N; Ogawa O; Nishiyama H
J Urol; 2010 Sep; 184(3):1175-81. PubMed ID: 20663523
[TBL] [Abstract][Full Text] [Related]
55. An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.
Zhang Z; Hou L; Feng L; Huang S; Luo M; Shao S; Zhang X; Gu S; Zhao X
Tumour Biol; 2015 Sep; 36(10):8167-75. PubMed ID: 25990455
[TBL] [Abstract][Full Text] [Related]
56. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.
Sun H; Luo L; Lal B; Ma X; Chen L; Hann CL; Fulton AM; Leahy DJ; Laterra J; Li M
Nat Commun; 2016 Feb; 7():10339. PubMed ID: 26842342
[TBL] [Abstract][Full Text] [Related]
57. Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells.
Lu J; Zheng X; Li F; Yu Y; Chen Z; Liu Z; Wang Z; Xu H; Yang W
Oncotarget; 2017 Feb; 8(9):15539-15552. PubMed ID: 28107184
[TBL] [Abstract][Full Text] [Related]
58. Recognition of murine integrin beta 1 by a rat anti-stromal cell monoclonal antibody.
Wu X; Miyake K; Medina KL; Kincade PW; Gimble JM
Hybridoma; 1994 Oct; 13(5):409-16. PubMed ID: 7532155
[TBL] [Abstract][Full Text] [Related]
59. How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.
Erman A; Kamenšek U; Dragin Jerman U; Pavlin M; Čemažar M; Veranič P; Romih R
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199232
[TBL] [Abstract][Full Text] [Related]
60. Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.
Kim WT; Seo SP; Byun YJ; Kang HW; Kim YJ; Lee SC; Jeong P; Seo Y; Choe SY; Kim DJ; Kim SK; Moon SK; Choi YH; Lee GT; Kim IY; Yun SJ; Kim WJ
Int J Oncol; 2017 Jul; 51(1):204-212. PubMed ID: 28498422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
